Usefulness of the Artery First Approach in Pancreatic Cancer Surgery (NCT04136522) | Clinical Trial Compass
UnknownNot Applicable
Usefulness of the Artery First Approach in Pancreatic Cancer Surgery
South Korea268 participantsStarted 2020-01-10
Plain-language summary
This study is aimed to evaluate difference of the 2 year recurrence free survival after pancreaticoduodenectomy for pancreatic cancer between artery-first approach and conventional procedure groups.
Who can participate
Age range20 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Resectable pancreatic head cancer
* No systemic metastasis
* Age \> 20 years
* The patients who understand informed consent and is able to agree with study
Exclusion Criteria:
* The patients who have systemic metastasis
* The patients who need neoadjuvant therapy in borderline resectable and locally advanced pancreatic cancer
* Those with active or uncontrolled infections
* Those with severe psychiatric / neurological disorders
* Alcohol or other drug addicts
* Patients with moderate or severe comorbidities who are thought to have an impact on quality of life or nutritional status (cirrhosis, chronic kidney failure, heart failure, etc.)